Point-of-care microvolume cytometer measures platelet counts with high accuracy from capillary blood

PLoS One. 2021 Aug 26;16(8):e0256423. doi: 10.1371/journal.pone.0256423. eCollection 2021.

Abstract

Background: Point-of-care (PoC) testing of platelet count (PLT) provides real-time data for rapid decision making. The goal of this study is to evaluate the accuracy and precision of platelet counting using a new microvolume (8 μL), absolute counting, 1.5 kg cytometry-based blood analyzer, the rHEALTH ONE (rHEALTH) in comparison with the International Society of Laboratory Hematology (ISLH) platelet method, which uses a cytometer and an impedance analyzer.

Methods: Inclusion eligibility were healthy adults (M/F) ages 18-80 for donation of fingerprick and venous blood samples. Samples were from a random N = 31 volunteers from a single U.S. site. Samples were serially diluted to test thrombocytopenic ranges. Interfering substances and conditions were tested, including RBC fragments, platelet fragments, cholesterol, triglycerides, lipids, anti-platelet antibodies, and temperature.

Results: The concordance between the rHEALTH and ISLH methods had a slope = 1.030 and R2 = 0.9684. The rHEALTH method showed a correlation between capillary and venous blood samples (slope = 0.9514 and R2 = 0.9684). Certain interferents changed platelet recovery: RBC fragments and anti-platelet antibodies with the ISLH method; platelet fragments and anti-platelet antibodies on the rHEALTH; and RBC fragments, platelets fragments, triglycerides and LDL on the clinical impedance analyzer. The rHEALTH's precision ranged from 3.1-8.0%, and the ISLH from 1.0-10.5%.

Conclusions: The rHEALTH method provides similar results with the reference method and good correlation between adult capillary and venous blood samples. This demonstrates the ability of the rHEALTH to provide point-of-care assessment of normal and thrombocytopenic platelet counts from fingerprick blood with high precision and limited interferences.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Assay
  • Blood Specimen Collection
  • Capillaries / cytology*
  • Flow Cytometry / instrumentation*
  • Humans
  • Microtechnology / instrumentation*
  • Middle Aged
  • Platelet Count
  • Point-of-Care Systems*
  • Young Adult

Grants and funding

Research reported in this publication was supported by AstraZeneca PLC and the National, Heart, Lung, Blood Institute of the National Institutes of Health under award number R44 HL099092. AstraZeneca provided support in the form of salary support for the authors HUW, JP, PS, AT, AE, and JS. These authors participated in study design, analysis, and preparation of the manuscript.